ENTRY       D06109                      Drug
NAME        Thioguanine (USP);
            Thioguanine hydrate;
            Tabloid (TN);
            Thioguanine (TN)
PRODUCT     TABLOID (Aspen Global)
            TABLOID (Waylis Therapeutics LLC)
            TABLOID (Woodward Pharma Services LLC)
FORMULA     C5H5N5S. xH2O
CLASS       Antineoplastic
             DG02018  Antimetabolite
              DG01958  Nucleic acid derivative, antineoplastic
REMARK      ATC code: L01BB03
            Chemical structure group: DG00684
            Product (DG00684): D06109<US>
EFFICACY    Antineoplastic, Antimetabolite
  DISEASE   Chronic myelogenous leukemia [DS:H00004]
            Acute nonlymphocytic leukemias [DS:H00003]
TARGET      HPRT1 [HSA:3251] [KO:K00760]
  PATHWAY   hsa00230(3251)  Purine metabolism
INTERACTION  
STR_MAP     map07041  Antineoplastics - antimetabolic agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01B ANTIMETABOLITES
                L01BB Purine analogues
                 L01BB03 Tioguanine
                  D06109  Thioguanine (USP) &lt;US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Antimetabolites
               Thioguanine
                D06109  Thioguanine (USP)
            Drug groups [BR:br08330]
             Antineoplastic
              DG02018  Antimetabolite
               DG01958  Nucleic acid derivative, antineoplastic
                DG00684  Tioguanine
                 D06109  Thioguanine
            Drug classes [BR:br08332]
             Antineoplastic
              DG02018  Antimetabolite
               D06109  Thioguanine
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Transferases (EC2)
               Pentosyltransferases
                HPRT1
                 D06109  Thioguanine (USP) &lt;US&gt;
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D06109
            Drug groups [BR:br08330]
             Antineoplastic
              DG02018  Antimetabolite
               DG01958  Nucleic acid derivative, antineoplastic
                DG00684  Tioguanine
DBLINKS     PubChem: 47207767
            LigandBox: D06109
ATOM        12
            1   C8y C    10.4632  -17.7007
            2   C8y C    10.3989  -16.2968
            3   N5x N    11.6740  -18.3967
            4   N4x N     9.1353  -18.1276
            5   C8y C    11.6740  -15.6007
            6   N5x N     9.1353  -15.8639
            7   C8y C    12.8906  -17.7007
            8   C8x C     8.3106  -16.9987
            9   N5x N    12.8906  -16.2968
            10  S1a S    11.6798  -14.1968
            11  N1a N    14.1074  -18.3909
            12  O0  O    19.1800  -17.0100
BOND        12
            1     1   2 2
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     2   6 1
            6     3   7 2
            7     4   8 1
            8     5   9 2
            9     5  10 1
            10    7  11 1
            11    6   8 2
            12    7   9 1
BRACKET     1    17.0100  -17.9200   17.0100  -16.0300
            1    19.8100  -16.0300   19.8100  -17.9200
            1  x
  ORIGINAL  1   12
  REPEAT    1 
///
